The Kv7 modulator, retigabine, is an efficacious antiseizure drug for delayed treatment of organophosphate-induced status epilepticus

Publication date: Available online 6 April 2021Source: NeuroscienceAuthor(s): Bryan S. Barker, Jay Spampanato, Hilary S. McCarren, Kyle Berger, Cecelia E. Jackson, David T. Yeung, F. Edward Dudek, John H. McDonough
Source: Neuroscience - Category: Neuroscience Source Type: research